Match valuation to its purpose
Purchase, sale, succession and finance require transparent assumptions, risks and scenarios.
- Sustainable earnings
- Location and lease risks
- Inventory and working capital
- Value range and sensitivities
Service area · Entrepreneurial pharmacy management
Pharmacy valuation for purchase, sale and succession
Buying a pharmacy requires more than agreeing a price: location, earnings, financing, operating licence and team must work together before signing.
Discuss your project →Acquisition · finance · handover
Pharmacy valuation
Buying a pharmacy requires more than agreeing a price: location, earnings, financing, operating licence and team must work together before signing.
tiger.PHARMA structures the review, makes opportunities and risks visible and connects commercial, operational and regulatory workstreams.
tiger.PHARMA Kompetenz
Topics we master
Distinguish valuation methods and deliverables
Forward-looking earnings and cash-flow scenarios form the core assessment. Market and asset evidence are used for plausibility, while inventory, fixed assets and working capital remain visible. The required deliverable—an initial value indication, a detailed decision paper or a formal expert opinion—is agreed before work starts.
- Earnings value and sustainable cash flow
- Market and asset plausibility
- Value indication or detailed report
- Clear boundary to legal, tax and statutory expert work
Agree process, documents and effort before starting
A confidential first discussion defines purpose, valuation date, sites, data room and required depth. Scope, timetable and fee can then be quoted responsibly.
- Purpose and recipients
- Data request and plausibility review
- Analysis, scenarios and value range
- Results discussion and next decisions
Review the business and location
We bring together trading data, prescription mix, footfall, competition, local healthcare environment and lease terms.
- Assess earnings, margin and cost base
- Location, competition and potential analysis
- Review premises, lease and development options
Control finance and risk
Purchase price, working capital, investment and liquidity are evaluated in a realistic start-up and transition scenario.
- Business plan and liquidity forecast
- Structured finance documentation
- Prioritised risks, requirements and open items
Execute the handover
We coordinate due diligence and operational transition alongside legal, tax and finance advisers.
- Licence and transition timeline
- Team and partner communication
- Stable procurement and supply from day one
FAQ
Frequently asked questions
How much does a pharmacy valuation cost?
The fee depends on the purpose, number of sites, data quality, required documentation and review effort. A specific scope and quotation follow once these points are clear; a flat price without a defined mandate would not be reliable.
How long does a pharmacy valuation take?
Timing depends mainly on data availability, number of sites, open questions and required documentation. A realistic milestone plan is agreed after an initial data-room review.
What does the process of buying a pharmacy involve?
The usual stages are acquisition profile and screening, confidentiality agreement, initial review, indicative offer, due diligence, finance and negotiation, contract, operating licence and operational handover.
How is the purchase price of a pharmacy assessed?
Sustainable earnings and cash flow matter more than revenue alone. Owner input, people cost, rent, procurement terms, exceptional items, investment and location outlook are normalised.
Which documents are needed for pharmacy due diligence?
Typical evidence includes accounts and management reports, prescription and assortment data, employment and lease documents, supplier and cooperation agreements, asset and inventory data, QMS records, authority correspondence, IT, privacy and insurance information.
How much equity is needed to buy a pharmacy?
That depends on price, inventory, investment, debt service, personal circumstances and lender requirements. A robust model also includes transaction costs, opening liquidity and a contingency reserve.